Investigating the Mechanism of Hedysarum Multijugum Maxim in the Treatment of Liver Cancer through Network Pharmacology and Molecular Docking Validation.

IF 2.5 3区医学 Q3 ONCOLOGY Oncology Pub Date : 2024-12-16 DOI:10.1159/000542990

Nan Wang, Liwen Tang, Ronghui Duan, Yuhong Shu

{"title":"Investigating the Mechanism of Hedysarum Multijugum Maxim in the Treatment of Liver Cancer through Network Pharmacology and Molecular Docking Validation.","authors":"Nan Wang, Liwen Tang, Ronghui Duan, Yuhong Shu","doi":"10.1159/000542990","DOIUrl":null,"url":null,"abstract":"Introduction: Hedysarum Multijugum Maxim (HMM), a Chinese traditional medicine , exerts anti-tumor effects and has been extensively studied for its potential to treat cancer in recent years. Clinical research has shown that HMM can control hepatocellular cancer, but the exact molecular mechanism is unclear.Methods: To identify the principal bioactive constituents of HMM and their corresponding targets, we constructed a protein-protein interaction (PPI) network. Secondly, the Cytoscape software was utilized to delineate the relationships among drugs, active components, targets, and illnesses. Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis using the clusterProfiler tools on the DAVID platform and the Bioconductor package in R. Molecular docking was performed on the PubChem database, whereas the AutoDock, and PyMOL software were utilized to explore the binding affinity of the primary targets and active molecules.Results: Network pharmacology and molecular docking analyses identified six key active constituents of HMM: quercetin, kaempferol, formononetin, isorhamnetin, calycosin, and 7-O-methylisomucronulatol. It was predicted that this herb can modulate the expression of several genes, including TP53, AKT1, MYC, CASP3, VEGFA, EGFR, HIF1A, ESR1, CCND1, and PTGS2.Conclusion: HMM has potential therapeutic effects on the liver cancer. This study provides important insights regarding the methods for investigating HMM in the treatment of hepatocellular cancer.","PeriodicalId":19497,"journal":{"name":"Oncology","volume":" ","pages":"1-24"},"PeriodicalIF":2.5000,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000542990","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Hedysarum Multijugum Maxim (HMM), a Chinese traditional medicine , exerts anti-tumor effects and has been extensively studied for its potential to treat cancer in recent years. Clinical research has shown that HMM can control hepatocellular cancer, but the exact molecular mechanism is unclear.

Methods: To identify the principal bioactive constituents of HMM and their corresponding targets, we constructed a protein-protein interaction (PPI) network. Secondly, the Cytoscape software was utilized to delineate the relationships among drugs, active components, targets, and illnesses. Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis using the clusterProfiler tools on the DAVID platform and the Bioconductor package in R. Molecular docking was performed on the PubChem database, whereas the AutoDock, and PyMOL software were utilized to explore the binding affinity of the primary targets and active molecules.

Results: Network pharmacology and molecular docking analyses identified six key active constituents of HMM: quercetin, kaempferol, formononetin, isorhamnetin, calycosin, and 7-O-methylisomucronulatol. It was predicted that this herb can modulate the expression of several genes, including TP53, AKT1, MYC, CASP3, VEGFA, EGFR, HIF1A, ESR1, CCND1, and PTGS2.

Conclusion: HMM has potential therapeutic effects on the liver cancer. This study provides important insights regarding the methods for investigating HMM in the treatment of hepatocellular cancer.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

求助全文

约1分钟内获得全文去求助

来源期刊

Oncology 医学-肿瘤学

CiteScore

6.00

自引率

2.90%

发文量

审稿时长

6-12 weeks

期刊介绍： Although laboratory and clinical cancer research need to be closely linked, observations at the basic level often remain removed from medical applications. This journal works to accelerate the translation of experimental results into the clinic, and back again into the laboratory for further investigation. The fundamental purpose of this effort is to advance clinically-relevant knowledge of cancer, and improve the outcome of prevention, diagnosis and treatment of malignant disease. The journal publishes significant clinical studies from cancer programs around the world, along with important translational laboratory findings, mini-reviews (invited and submitted) and in-depth discussions of evolving and controversial topics in the oncology arena. A unique feature of the journal is a new section which focuses on rapid peer-review and subsequent publication of short reports of phase 1 and phase 2 clinical cancer trials, with a goal of insuring that high-quality clinical cancer research quickly enters the public domain, regardless of the trial’s ultimate conclusions regarding efficacy or toxicity.